---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-001110"
form_type: "8-K"
ticker: "LCTC"
cik: "0001493137"
company_name: "Lifeloc Technologies, Inc"
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T15:57:12.592084+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lifeloc raises $798K via private placement, appoints new director, secures $750K credit line

## Summary
- Issued 210,000 shares at $3.80 to EDCO Partners, raising $798K; EDCO now holds 77.5% of common stock.
- Robert Greenlee resigned from board; replaced by Adam Kashenberg, CEO of Colorado Biolabs, effective July 23.
- Obtained $750K line of credit from Citywide Banks on July 19, 2024.
- Plans beta testing of saliva THC test (SpinDx) in 2024, targeting commercial launch in 2025.

## SEC filing metadata
- accession: 0001079973-24-001110
- form_type: 8-K
- ticker: LCTC
- cik: 0001493137
- company_name: Lifeloc Technologies, Inc
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/0001079973-24-001110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/lctc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-001110
- JSON: https://secwatch.observer/filing/0001079973-24-001110.json
- Plain text: https://secwatch.observer/filing/0001079973-24-001110.txt

## Key facts
- Executive change
  Robert Greenlee resigned as Director at Lifeloc Technologies, Inc.
  - Action: resigned
  - Role: Director
  source text: On July 22, 2024, Robert Greenlee notified the Company by letter of his resignation from the board of directors (the “Board”) of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/0001079973-24-001110-index.htm
- Executive change
  Adam Kashenberg was appointed as Director at Lifeloc Technologies, Inc.
  - Action: appointed
  - Role: Director
  source text: On July 23, 2024, in accordance with the Company’s Amended and Restated Bylaws (the “Bylaws”), the Board appointed Adam Kashenberg to fill the vacancy on the Board and on the Company’s audit committee created by Mr. Greenlee’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1493137/000107997324001110/0001079973-24-001110-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.